Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 7/20 | 0.69 |
| ▸ | MCL1 | Q07820 | 7/20 | 0.69 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.69 |
| ▸ | BAK1 | Q16611 | 6/20 | 0.69 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.69 |
| ▸ | PPARA | Q07869 | 3/20 | 0.69 |
| ▸ | PPARG | P37231 | 2/20 | 0.69 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.69 |
| ▸ | EP300 | Q09472 | 2/20 | 0.69 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.69 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.69 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.69 |
| ▸ | F7 | P08709 | 3/20 | 0.59 |
| ▸ | F3 | P13726 | 3/20 | 0.59 |
| ▸ | MMP2 | P08253 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ECE1 | P42892 | 1/20 | 0.59 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30069215 | 1.00 | BID (0.69) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL301487 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL23277 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL795643 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL485756 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL3258790 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL3033684 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL10767415 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5519496 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5424052 | 0.98 | BID (0.72) | BIDMCL1BCL2L1BAK1KAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10814303-B2 | Process for producing a calcium phosphate reactant, reactant obtained and use thereof in the purification of liquid effluents | SOLVAY SA (BE) | 2020-10-27 | — | — | US | claimed |
| EP-4543455-A2 | METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY | Enalare Therapeutics Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025080559-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20250114370-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC (US) | 2025-04-10 | — | — | US | disclosed |
| EP-4504206-A2 | RESPIRATORY STIMULANT NASAL FORMULATIONS | Enalare Therapeutics Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| US-20250032496-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | ENALARE THERAPEUTICS INC (US) | 2025-01-30 | — | — | US | disclosed |
| US-20250031718-A1 | NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | SOVIDA SOLUTIONS LTD (GB) | 2025-01-30 | — | — | US | disclosed |
| US-20250010049-A1 | ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES | Biograil ApS (DK) | 2025-01-09 | — | — | US | disclosed |
| US-12150461-B2 | Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof | Sovida Solutions Ltd. (GB) | 2024-11-26 | — | — | US | disclosed |
| US-12138267-B2 | Methods of treating respiratory depression modulated by a non-opioid agent | ENALARE THERAPEUTICS INC. (US) | 2024-11-12 | — | — | US | disclosed |
| EP-0442078-A1 | Method and agent for the purification of gases and exhaust gases | ARASIN GMBH (DE) | 1991-08-21 | — | — | EP | disclosed |
| US-5024929-A | Method of preparing coupler dispersions for photographic use | EASTMAN KODAK COMPANY (US) | 1991-06-18 | — | — | US | disclosed |
| US-4946768-A | NON-DIFFUSING; ABSORPTION OF SPECIFIC WAVELENGTHS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-08-07 | — | — | US | disclosed |
| EP-0127819-B1 | ULTRAVIOLET ABSORBER AND PHOTOGRAPHIC MATERIAL INCLUDING IT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-03-30 | — | — | EP | disclosed |
| EP-0210409-A2 | 3-Aminoallylidenemalononitrile uv-absorbing compounds and photographic elements containing them | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-02-04 | — | — | EP | disclosed |
| US-4576908-A | 3-DIALLYLAMINOALLYLIDENEMALONITRILE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
| EP-0127819-A2 | Ultraviolet absorber and photographic material including it | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-12-12 | — | — | EP | disclosed |
| US-4297438-A | USING HYDROPHILIC AND HYDROPHOBIC DEVELOPERS COMPRISING N-SULFOALKYL-N-ALKYL-P-DIAMINOBENZENES | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1981-10-27 | — | — | US | disclosed |
| EP-0007593-B1 | COLOUR-PHOTOGRAPHIC DEVELOPING PROCESS | Agfa-Gevaert AG (DE) | 1981-01-21 | — | — | EP | disclosed |
| EP-0007593-A1 | Colour-photographic developing process | Agfa-Gevaert AG (DE) | 1980-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250010049-A1 | ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES | ABCB1, EPCAM, ABCB11 | BID 604/4885MCL1 2683/4885BCL2L1 2781/4885 |
| US-12138267-B2 | Methods of treating respiratory depression modulated by a non-opioid agent | OPRK1, OPRM1, OPRD1 | BID 3419/4885MCL1 4481/4885BCL2L1 4029/4885 |
| US-20250032496-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | OPRK1, OPRM1, OPRD1 | BID 3419/4885MCL1 4481/4885BCL2L1 4029/4885 |
| US-20250114370-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ADRA2A, ADRA2C, OPRM1 | BID 297/4885MCL1 687/4885BCL2L1 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.